01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
C. Considerations of chromatin structure<br />
of plasmids during gene delivery<br />
Almost all supercoiled plasmids used in gene transfer,<br />
as produced in bacteria, are under negative supercoiling.<br />
Immediately after their import into nuclei plasmids are<br />
packaged into nucleosomes that absorb and constrain part<br />
or most likely all of the negative supercoils. This is true<br />
assuming that no cuts on the DNA are introduced during<br />
its passage through the cell membrane barrier to<br />
cytoplasmic lysosomes before entering nuclei; if DNA is<br />
cut the supercoils on the plasmid will be relaxed. Nicked<br />
DNA might be repaired and ligated in nuclei by DNA<br />
ligases and be subject to the same constrains as<br />
chromosomal DNA. Use of linear plasmids is expected to<br />
stimulate recombination during repair of double strand<br />
breaks (also would increase degradation of the plasmid in<br />
the nucleus and loss of the transgene) ultimately resulting<br />
in plasmid integration at variable chromosomal loci,<br />
determined to some extend by the nature of the free ends<br />
of DNA and the short terminal sequence of the DNA at the<br />
ends as well as the type of recombinase molecules in the<br />
cell type used.<br />
Treatment of cell cultures with sodium butyrate<br />
inducing hyperacetylation of core histones would reverse<br />
in part the relieving of the negative torsional strain by the<br />
wrapping of the plasmid around histone octamers and will<br />
provide DNA in a negatively superhelical of underwound<br />
form able to sustain transcription of the template (Schlake<br />
et al, 1994).<br />
D. Overcoming the influences of<br />
chromosomal surroundings at plasmid<br />
integration sites<br />
Use of two MARs each flanking the reporter gene on<br />
either side is expected to form a minidomain after<br />
integration of the foreign gene into a chromosomal site.<br />
MARs potentiate the effect of promoters and enhancers<br />
when two MAR elements are placed one upstream and the<br />
other downstream from control elements but not between<br />
them. MARs will (i) shield reporter genes from the<br />
influences of chromosomal surroundings that most often<br />
cause inactivation of foreign genes. This effect of<br />
chromatin structure on neighboring sequences is known as<br />
position effect variegation. Indeed about 85% of the<br />
chromosomal sites are transcriptionally inactive assuming<br />
that 15% of the genomic DNA is transcribed; however,<br />
even integration of a foreign gene into an active chromatin<br />
<strong>Gene</strong> Therapy and <strong>Molecular</strong> <strong>Biology</strong> Vol 1, page 41<br />
41<br />
locus may not warrantee its transcriptional activation as<br />
other parameters, such as proximity of the integration site<br />
to the natural promoter and enhancer elements of the<br />
active chromatin domain, or orientation of the integrated<br />
gene with respect to the active gene in the chromosomal<br />
DNA may determine its level of expression. (ii) MARs<br />
will maintain a supercoiled DNA topology within the<br />
domain thus increasing the negative supercoiling at local<br />
promoter and enhancer sites, a prerequisite for efficient<br />
transcription (see <strong>Boulikas</strong>, 1995b).<br />
XIV. Transfer of reporter genes<br />
A. Transfer of the β-galactosidase (lacZ)<br />
reporter gene<br />
Before a gene <strong>therapy</strong> preclinical study or even gene<br />
transfer to cells in culture begins it is essential to test the<br />
variables and pinpoint the conditions leading to the<br />
success of the operation using reporter gene transfer.<br />
LacZ, encoding the β-galactosidase (β-Gal) from E. coli is<br />
one of the most commonly used reporter genes. A staining<br />
procedure for this enzymatic activity can result in the<br />
generation of blue color using X-Gal as a substrate leading<br />
to the direct visualization of its activity, for example, in<br />
thin sections through animal tissues.<br />
Transfer of the reporter β-galactosidase gene to human<br />
liver tumors in nude mice was performed by Wang and<br />
Vos (1996) using a hybrid HSV-1/EBV vector which<br />
replicates episomally when the latent oriP of EBV and the<br />
EBNA-1 cDNA were included.<br />
Many mammalian tissues, especially intestine, kidney,<br />
epididymis, and lung contain endogenous β-Gal, a<br />
lysosomal enzyme participating biochemically in<br />
glycolipid digestion. Weiss et al (1997) were able to detect<br />
mammalian β-Gal activity on histochemical preparations<br />
of mouse, rat and baboon lung tissue (Figure 16) and also<br />
to distinguish between the endogenous and bacterial β-Gal<br />
activity in airway epithelial cells in the transgenic Rosa-26<br />
mouse in based upon the differences in pH optima<br />
between the mammalian and bacterial enzymes (Figure<br />
17). Time and temperature of exposure to X-Gal could not<br />
be used to distinguish between endogenous and exogenous<br />
β-Gal activity; thus, exposure of tissue preparation to pH<br />
8.0-8.5, which minimized detection of the endogenous<br />
activity allowed unambiguous discrimination and was the<br />
method of choice to detect reporter β-Gal activity.